Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucin disulfide networks are the fundamental structural framework of the airway mucus gel, primarily composed of the large, secreted polymeric glycoproteins MUC5AC and MUC5B [Fahy, 2010]. These mucins undergo extensive post-translational modification and form massive, high-molecular-weight oligomers through disulfide bond formation between cysteine-rich D-domains at their N- and C-termini [Thornton, 2008]. This cross-linked network is essential for the viscoelastic properties of mucus, which allow it to trap inhaled particles and be transported out of the lungs by ciliary action [Bonser, 2017]. In pathological states like cystic fibrosis, COPD, and severe asthma, the density of these disulfide cross-links increases or the mucus becomes dehydrated, resulting in stagnant, thick mucus that obstructs the airways and promotes infection [Bonser, 2017]. Therapeutic intervention typically utilizes mucolytic agents, such as N-acetylcysteine, which contain free thiol groups that participate in thiol-disulfide exchange reactions to break the mucin polymers into smaller, less viscous fragments [Yuan, 2015]. By reducing the connectivity of the disulfide network, these drugs facilitate the clearance of obstructive mucus and improve lung function in patients with chronic respiratory diseases [Fahy, 2010].
Reduction of intermolecular disulfide bonds via thiol-disulfide exchange, leading to the fragmentation of mucin polymers and reduction of mucus viscoelasticity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucin disulfide networks in airway mucus.